|
Cannabidiol Clinical Trials
6 actively recruiting trials across 5 locations
Also known as: CBD, CBD Oil, Epidiolex, GWP42003-P
Pipeline
Phase 2: 3Phase 3: 1Phase 4: 1Phase 1/2: 1
Top Sponsors
- University of Colorado, Denver1
- University of British Columbia1
- Mclean Hospital1
- Massachusetts Institute of Technology1
- Icahn School of Medicine at Mount Sinai1
Indications
- Anxiety3
- Bipolar Disorder2
- Depression2
- Early Life Adversity1
- Phobia, Social1
Other1 trial
Duarte, California1 trial
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
City of Hope Medical Center
Phase 2
Aurora, Colorado1 trial
CBD for Individuals at Risk for Alzheimer's Disease
University of Colorado - Anschutz Medical Campus
Phase 2
Belmont, Massachusetts1 trial
Phase 2
Cambridge, Massachusetts1 trial
Investigating the Effects of Cannabidiol on Social Anxiety Disorder
Massachusetts Institute of Technology
Phase 4
New York, New York1 trial
Study of Cannabidiol and Neuroimaging on Stress
Ichan School of Medicine at Mount Sinai
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.